



Crystal structure of TNFα complexed with 
a poxvirus MHC-related TNF binding protein 
 













Protein expression and crystallization. The gene for 2L was isolated by PCR from the 
Yaba-like disease virus (ATCC number VR-937). A C-terminally His-tagged version of 
2L lacking six C-terminal residues (residues 1-316 of the mature protein) was expressed 
together with human β2m in baculovirus-infected insect cells (Hi5 cells) using a 
dicistronic baculovirus transfer vector, pAcUW31 (PharMingen). The 2L and β2m genes 
used for expression both included native hydrophobic leader sequences. In our numbering 
system for 2L, the first amino acid of the mature 2L chain is residue 1; a previous 
numbering system, which started at the initial methionine of the signal peptide, refers to 
this residue as 171-3. 2L was purified by nickel-NTA and gel filtration chromatography. 
Although the expression was conducted using methods that resulted in stable heavy 
chain/β2m heterodimers for other MHC homologs4, β2m was not detected in purified 2L 
preparations (data not shown).  
A N-terminally His-tagged form of human TNFα (residues 6-157, numbered as in 
PDB entry 1TNF) was expressed in the E. coli cytoplasm using the expression vector 
pET23a (Novagen), and soluble TNFα was purified from bacterial lysates by nickel-NTA 
and gel filtration chromatography. 
 Purified 2L and TNFα trimer were mixed at a 3:1 molar ratio and passed over a 
S200 16/60 gel filtration column in 20 mM Tris pH 7.5, 150 mM NaCl. Consistent with 
previous reports1-3, monomeric 2L lacking β2m bound stably to TNFα. The 2L–TNFα 
complex was isolated and then concentrated to 14 mg/ml and used to set up 
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crystallization trials by hanging drop vapor diffusion. Crystals were obtained in 7-12% 
PEG 6K, sodium citrate pH 5.0-5.5, 0.2 M NaBr in monoclinic space group P21 (a = 
101.7, b = 170.3, c =122.0, β = 92.04˚) with two 3:1 2L–TNFα complexes per 
asymmetric unit. The crystal used for data collection had been soaked in 0.5 mM 
methylmercury chloride, but no heavy atoms were found in the refined structure. 
X-ray crystallography. Diffraction data were collected at beamline 11-1 of the Stanford 
Synchrotron Radiation Laboratory; wavelength of data collection was 1.0047 Å. The 
dataset was collected at 100 K from a single crystal. The data were processed using 
HKL20005 (Supplementary Table 1). The structure was determined by molecular 
replacement using a TNFα search model (PDB code 1TNF)6 followed by location of 2L 
molecules using the coordinates of the α1-α2 platform of ZAG (PDB code 1T7V)7 in a 
real space search. After rigid-body refinement8, rebuilding was done using the program 
O9 and 2Fo-Fc annealed omit maps, alternating with refinement using CNS10. Non-
crystallographic symmetry (NCS) restraints (300 kcal/mol•Å2) and group B factor 
refinement were used during refinement. Ordered carbohydrate was attached to 2L 
residues Asn6, Asn52, and Asn83, but not to Asn197, the remaining potential N-linked 
glycosylation site in the 2L sequence. The following cysteine pairs were disulfide 
bonded: 2L 97-163 (difference Fourier maps indicated some radiation-induced breakage 
of this bond11), 202-281, 295-299, and TNFα 69-101. 2L residues 300-316, its C-terminal 
His-tag, and the N-terminal His-tag of TNFα were disordered. The final model consisted 
of six NCS-related sets of atoms: 2L residues 1–299, TNFα residues 6–157, 16 water 
molecules, and 42 atoms of carbohydrate. A Ramachandran plot determined that 80.4% 
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of residues are in the most favored region, 14.5% are in the additional allowed region, 
4.0% are in the generously allowed region, and 1.0% are in the disallowed region. 
For analysis of contacts and buried surface areas, the 2L α1-α2 platform was defined as 
residues 1-179 and the α3 domain was defined as residues 180-299. The CCP4 program 
AREAIMOL12 was used to calculate buried surface areas using a 1.4 Å probe. To identify 
interacting residues, a maximum distance of 4.0 Å for van der Waals interactions was 
used. Shape complementarity indices (SC) were calculated as described13 using the Sc 
program in CCP412. Groove surface area calculations were performed as previously 
described14,15. Structural superpositions were performed using LSQMAN16. Figures were 
prepared with MOLSCRIPT17, RASTER-3D18, and PyMOL19. The domain angle displacement 
for the 2L α3 domain relative to the HLA-A2 α3 domain (~42°) was calculated by 
measuring the angle between the long axes of each domain after alignment of the α1-α2 
platforms of both molecules. The long axes of the α3 domains were defined using the 
coordinates of 2L residues Gly176 and Asn191 and HLA-A2 residues Glu177 and 
His192. The second rotation angle (~40°) relating the α3 domains was estimated using 
the angle defined by 2L Arg270 and Asn191 and HLA-A2 Val248. 
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 Supplementary Table 1.  Data collection and refinement statistics 
 
 2L–TNFα   
Data collection  
Space group P21 
Cell dimensions    
    a, b, c (Å) 101.7, 170.3, 122.0 
    β  (°)  92.04 
Resolution (Å) 50.0-2.80 (2.90-2.80)* 
Rsym or Rmerge 8.1 (47.2) 
I / σI 16.5 (2.3) 
Completeness (%) 96.8 (81.0) 
Redundancy 3.7 (3.4) 
  
Refinement  
Resolution (Å) 50.0-2.80 
No. reflections 98697 
Rwork / Rfree 23.6 / 26.6 
No. atoms  
    Protein 21660 
    Ligand/ion 252 
    Water 96 
B-factors  
    Protein 74.0 
    Ligand/ion 108.7 
    Water 48.4 
R.m.s. deviations  
    Bond lengths (Å) 0.007 
    Bond angles (°) 1.48 
Data were collected on a single crystal, and in the refinement, 5% of unique reflections 
were removed as a test set for Rfree calculation. *Values in parentheses are for highest-
resolution shell. 
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 Supplementary Table 2. Root mean square deviations (RMSD) for superpositions of the 
α1-α2 platform of 2L with platforms of MHC and MHC-like molecules. 
 
 
Protein  RMSD  Cαs aligned PDB code ref. 
HLA-A2 1.43 Å  104 atoms 2CLR  1 
M10.5  1.45 Å  105 atoms 1ZS8  2 
UL18  1.56 Å  105 atoms 3D2U  3 
ZAG  1.69 Å  107 atoms 1ZAG  4 
T22  1.70 Å  96 atoms 1C16  5 
FcRn  1.73 Å  123 atoms 1EXU  6 
CD1d1  1.75 Å  113 atoms 1CD1  7 
m153  1.75 Å  75 atoms 2O5N  8 
HFE  1.77 Å  102 atoms 1A6Z  9 
m144  1.81 Å  90 atoms 1U58  10 
m157  1.83 Å  80 atoms 2NYK  11 
MIC-A 1.85 Å  103 atoms 1HYR  12 
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 Supplementary Table 3. Interactions between 2L and TNFα. % ASA (accessible surface 
area) = percent of the total interface ASA contributed by each residue. Residues 
contributing less that 2% of interface ASA were excluded unless they are involved in 
hydrogen bonds or salt bridges (indicated by asterisks). 
 
  2L       TNFα 
Residue Location  %ASA Residue (subunit) Location 
 
HIS58* α1 helix  4 TYR87  (B)  D-E loop 
 
GLU99* β5 strand  6 ARG31  (A)  A-A’ loop 
GLU99* β5 strand   ARG32  (A)  A-A’ loop 
GLY101 β5-β6 loop 2 ARG31  (A)  A-A’ loop 
PHE104 β6 strand  6 ASN30  (A)  A-A’ loop 
PHE104 β6 strand   ARG31  (A)  A-A’ loop 
LYS125 β7-β8 loop 5 SER86  (B)  D-E loop 
GLY157 α2 helix  3 SER86  (B)  D-E loop 
GLY157 α2 helix   TYR87  (B)  D-E loop 
TYR160 α2 helix  9 ARG82  (B)  D strand 
TYR160 α2 helix   SER86  (B)  D-E loop 
TYR160 α2 helix   GLU127 (B)  F-G loop 
MET161 α2 helix  8 ASN34  (A)  A-A’ loop 
MET161 α2 helix   ARG82  (B)  D strand 
MET161 α2 helix   VAL91  (B)  E strand 
GLY162 α2 helix  2 TYR87  (B)  D-E loop 
LEU165 α2 helix  3 ALA33  (A)  A-A’ loop 
LEU165 α2 helix   VAL91  (B)  E strand 
LEU168 α2 helix  3 ARG32  (A)  A-A’ loop 
GLN171 α2 helix  4 GLN21  (A)  A-A’ loop 
LYS175 α2 helix  4 GLN21  (A)  A-A’ loop 
 
GLU225* α3 insertion 2 ARG44  (A)  B’ strand 
VAL229 α3 insertion 5 GLU42  (A)  B’ strand 
VAL229 α3 insertion  ARG44  (A)  B’ strand 
ASN230 α3 insertion 7 ASN30  (A)  A-A’ loop 
ASN230 α3 insertion  LEU37  (A)  A’ strand 
ASN230 α3 insertion  LEU43  (A)  B’ strand 
GLY231 α3 insertion 6 LEU37  (A)  A’ strand 
GLY231 α3 insertion  VAL41  (A)  B’ strand 
GLY231 α3 insertion  GLU42  (A)  B’ strand 
ARG232* α3 insertion 5 GLU42  (A)  B’ strand 
ARG232 α3 insertion  ARG44  (A)  B’ strand 
GLU289 F-G loop  4 GLN27  (A)  A-A’ strand 
GLU289* F-G loop   ARG31  (A)  A-A’ strand 
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   YLDV 2L:  ITLKYNYTVTLKD DGLYDGVFY  DHYNDQLVTKISYNHET RHGNVN   45
    TPV 2L:  ITLKYNYTVTLKD NGLYDGVFY  DHYNDQLVTKISYNHET RHGNVN   45
   YMTV 2L:  ITLRYNYTVTVK  NGLYDGVFF  DYYNDQLVTRISYNHET RHGNVN   44
   Deerpox: ARYLVYNYTFTRYD KTTGKKEFDVTDTFNNVLIKHYKLNHETGRPEQKH   49
  Swinepox: SAFLVYNYTYTLQDDNHRYD  FEVTDYFNDILIKRLKLNSETGRPELRN   48
 Consensus: ---L-YNYT-T--D----YD--F---D--ND-L------NHET-R----N
                                                          
   YLDV 2L: FRADWFNISRSPHTPGNDYNFNFWYSLMKETLEEIN  KNDSTKTTSLSL   93
    TPV 2L: FRADWFNISRSPHTPGNDYNFNFWYSLMKETLEEIN  KNDSTKTTSLSL   93
   YMTV 2L: SRASWFDISKSPHTPGDDYHFNFWYPLMKDTLESINSNKNESDKCSSLSL   94
   Deerpox: TIPKWFNETKIKHYPKDDYHYSFWLGQLENTLSEIN  KLEGNKHESISL   97
  Swinepox: EPPTWFNETKIRYYPKNNYNFMFWLNRMSETLDEINKLPETSNPYKTMSL   98
 Consensus: ----WFN-----H-P--DY-F-FW---M--TL-EIN--K--S-K--S-SL
            
   YLDV 2L: ITGCYETGLLFGSYGYVETANGPLARYHTGDKRFTKMTHKGFPKVGMLTV   143
    TPV 2L: ITGCYETGLLFGSYGYVETANGPLARYHTGDKRFTKMTHKGFPKVGMLTV   143
   YMTV 2L: ILGCYETGSLFGSYGYVESSGGPLARYSTKDKKFLKMTDKGFPKVGMLTV   144
   Deerpox: IVGCTDLIQLYTQFGYVEVDGKILTRFDTKNKRFTKVKSHTFPKVGMLTV   147
  Swinepox: TIGCTDLRQLQVNFGYVTVGGNIWTRFDPKNKRFSKVRSRTFPKVGMLTV   148
 Consensus: I-GC-----L----GYVE-----L-R--T--KRF-K-----FPKVGMLTV
             
   YLDV 2L: KNTLWKDVKAYLGGFEYMGCSLAILDYQKMAKGKIPKDTTPTVKVTGNEL   193
    TPV 2L: KNTLWKDVKTYLGGFEYMGCSLAILDYQKMAKGEIPKDTTPTVKVTGNEL   193
   YMTV 2L: HGPSWQTVKKYVGGFVYAGCLLAIFDYQKMAKNNIPSNVMPTVTVTGEEL   194
   Deerpox: TSPFWNDIMKYFGSIVAVTCGITANDYWKLAKGNIPSPVEPKIKVTGKEK   197
  Swinepox: KSQHWERVMEHLGSMVTLTCPFTADDYYKISKGYIDKPVKPTVTVTGIER   198
 Consensus: ----W--V--Y-G------C-----DY-K-AKG-IP----PTV-VTG-E-
                                    
   YLDV 2L: EDGNMTLECTVNSFYPPDVITKWIESEHFKGEYKYVNGRYYPEWGRKSNY   243
    TPV 2L: EDGNMTLECSVNSFYPPDVITKWIESEHFKGEYKYVNGRYYPEWGRKSDY   243
   YMTV 2L: QDGNTTLKCNVKSFYPPDVMIKWIESKYFNGEYRYVNGREYPEWGRQSDY   244
   Deerpox: GE NTTLFCDFDKHNPSSVAAKWYNLEDLAPTYRW  SRYFTELIVDTDY   244
  Swinepox: GD NTTLICTFDNHYPSSVAVKWYNIEDFAPDYRY  DPYVNELLPDTDY   245
 Consensus: -D-N-TL-C-----YP--V--KW---E-F---Y-Y---RY--E-----DY
                     
   YLDV 2L: EPGEPGFPWNIKK DKDANTYSLTDLVRTTSKMSSQPVCVVFHDTLEAQV   292
    TPV 2L: EPGEPGFPWNIKK DKDANTYSLTDLVRTTSKMSSQLVCVVFHDTLEAQV   292
   YMTV 2L: EPGEPGFPLHPKK DDGKTTYSLLDFGRTTSGLTSQLVCVVFHDTFESQV   293
   Deerpox: NPGEPGFPTNTRIINETALVFASTPSIVVPTDMSNKIVCVGFHSTIQPSI   294
  Swinepox: LPGEPGYPTITRRLG DKYLFTSSPRVMVPTIMSNRIACVGFHSTLEPSI   294
 Consensus: -PGEPGFP------------------------MS---VCV-FH-T-E---
   YLDV 2L: YTCSEGCNGELYDHLYRKTEEG EGEEDEED                      322
    TPV 2L: YTCSEGCNGELYDHLYRKTEEG EGEEDEED                      322
   YMTV 2L: NTCSEGCEGKLYDHLYRKSEEGDEVVEDEED                      324
   Deerpox: HRCEEGCNG  PEPIMQYQGDVKSSIDDEED                      323
  Swinepox: YRCVN CSG  PEPVLQYQGDRRNDLEDEED                      322
 Consensus: --C-EGC-G-----------------EDEED
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Supplementary Figure 1. Sequence alignment of poxvirus 2L proteins. YLDV = Yaba-like
disease virus; TPV = Tanapox virus; YMTV = Yaba monkey tumor virus; Deerpox = Deerpox
virus strain W-848-83; Swinepox = Swinepox open reading frame SPV003. Consensus amino
acid is shown when identity is >70%. Secondary structures are indicated as springs for α-helices
and arrows for β-strands. Residues colored red indicate that the amino acid at this position
contacts TNFα in the YLDV 2L–TNFα complex structure.The different 2L proteins show varying
degrees of species specificity. For example, swinepox 2L binds tightly to porcine TNFα, but not
to human TNFα, and porcine TNFα does not bind well to TPV 2L (which has a high affinity for
human TNFα). Compensating differences in residues at the 2L–TNFα interface, such as the
substitution of TPV 2L residues Gly231-Arg232 for asparate and proline in swinepox 2L, and
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human TNFα residue Glu42 for a lysine in porcine TNFα (Supplementary Fig. 5), likely account
for species-specific binding preferences. Consistent with the varying degrees of specificity of
poxvirus 2L proteins for binding TNFα from different species, the TNFα binding site on 2L
(indicated in red) is less conserved than the rest of the protein: 26% (5 of 19) of the binding site
residues are conserved in 2L proteins from four or more poxviruses, compared with an overall
conservation of 42% (125 of 299 residues). Sequence diversity at the binding site is likely related
to adaptation of poxviruses to the TNFα of their host species. Variability in classical class I MHC
molecules primarily maps to a different location, the peptide-binding groove20.
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Supplementary Figure 2. Structure-based sequence alignment of 2L and the class I MHC
molecule HLA-A2. Secondary structures are indicated as springs for α-helices and arrows for
β-strands. Conserved residues are shown as white letters in red boxes, and conservative substitutions
are indicated as red letters. 2L residues that contact TNFα are indicated with downward-pointing
blue triangles. Residues in the HLA-A2 peptide-binding groove are indicated with upward-pointing
black triangles. Glycosylation sites are indicated with green stars. Disulfide bonds are indicated
with the same orange numeral above or below bonded cysteines. Residues critical for class I MHC
binding to the T cell co-receptor CD8 are indicated below the HLA-A2 sequence as purple stars.
A comparison with 2L indicates that it does not contain the canonical CD8 binding site found on
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Supplementary Figure 3. Comparison of 2L and MHC structures. a, Ribbon diagram of 2L with
the α3 domain insertion highlighted in dark blue. b, Stereo Cα superposition of the α1-α2 platforms
of 2L (magenta) with HLA-A2 (gray) and rat FcRn (green). Groove closure in 2L is partially
accomplished by displacement of the N-terminal half of each helix towards the opposite helix.
Although the 2L α2 domain helix includes a similar kink to that observed in the α2 domain helices
of FcRn and CD1 (indicated on the 2L structure with an arrow), 2L lacks the proline found near this
kink in other MHC homologs (residues at this position: 2L Ser164/FcRn Pro166/CD1a Pro167/
HLA-A2 Val165). c, A surface representation of the 2L α1-α2 platform shown in the same
orientation as in panel b. Residues contributing to the 60 Å2 of accessible groove surface area are
red, the TNFα binding site is blue, and one residue belonging to both sets is light blue. The surface
includes a small pocket (to the immediate right of the red residues) analogous to a pocket in the
MIC-A structure21. d, Stereo close-up of the interface between the 2L α1-α2 platform (magenta)
and α3 domain (light blue, with dark blue highlighting the insertion in the α3 domain). Sidechains
of residues involved in stabilizing the interface are highlighted and labeled. e, Stereo superposition
of 2L (magenta) and HLA-A2 (gray, with the β2m light chain in black). An arrow indicates the
displacement of the 2L α3 domain compared with the HLA-A2 α3 domain. The approximate
position of TNFα is indicated as an oval. f, Stereo representation of 2L (magenta) with β2m docked
in two possible positions (gray and black). The gray β2m is docked in the position it would occupy if
it interacted with the bottom of the 2L α1-α2 domain as β2m interacts with the HLA-A2 α1-α2 region.
The black β2m is docked in the position it would occupy if it interacted with the 2L α3 domain as β2m
interacts with HLA-A2 α3. The N-linked carbohydrate attached to 2L Asn6 is shown as yellow sticks.
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                            A                    A’    B’    B  
  
  human TNFα: VRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVV   50 
 monkey TNFα: VRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELTDNQLVV   50 
 canine TNFα: VKSSSRTPSDKPVAHVVANPEAEGQLQWLSRRANALLANGVELTDNQLIV   50 
Porcine TNFα: LRSSSQT SDKPVAHVVANVKAEGQLQWQSGYANALLANGVKLKDNQLVV   49 
 murine TNFα: LRSSSQNSSDKPVAHVVANHQVEEQLEWLSQRANALLANGMDLKDNQLVV   50 
 rabbit TNFα: LRSASRALSDKPLAHVVANPQVEGQLQWLSQRANALLANGMKLTDNQLVV   50 
  human TNFβ:           KPAAHLIGDPSKQNSLLWRANTDRAFLQDGFSLSNNSLLV   67 
   Consensus: -RSSS---SDKPVAHVVANP--EGQLQWL--RANALLANG--L-DNQLVV 
 
                         C                    D              E
               
  human TNFα: PSEGLYLIYSQVLFKGQG CP   STHVLLTHTISRIAVSYQTKVNLLSA   96 
 monkey TNFα: PSEGLYLIYSQVLFKGQG CP   SNHVLLTHTISRIAVSYQTKVNLLSA   96 
 canine TNFα: PSDGLYLIYSQVLFKGQG CP   STHVLLTHTISRFAVSYQTKVNLLSA   96 
Porcine TNFα: PTDGLYLIYSQVLFRGQG CP   STNVFLTHTISRIAVSYQTKVNLLSA   95 
 murine TNFα: PADGLYLVYSQVLFKGQG CP    DYVLLTHTVSRFAISYQEKVNLLSA   95 
 rabbit TNFα: PADGLYLIYSQVLFSGQG CR   S YVLLTHTVSRFAVSYPNKVNLLSA   95 
  human TNFβ: PTSGIYFVYSQVVFSGKAYSPKATSSPLYLAHEVQLFSSQYPFHVPLLSS   117 
   Consensus: P--GLYLIYSQVLF-GQG-CP---S--VLLTHT-SR-AVSYQ-KVNLLSA 
 
                                  F              G 
                                      
  human TNFα: IKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAE   146 
 monkey TNFα: IKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINLPDYLDFAE   146 
 canine TNFα: IKSPCQRETPEGTEAKPWYEPIYLGGVFQLEKGDRLSAEINLPNYLDFAE   146 
Porcine TNFα: IKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKDDRLSAEINLPDYLDFAE   145 
 murine TNFα: VKSPCPKDTPEGAELKPWYEPIYLGGVFQLEKGDQLSAEVNLPKYLDFAE   145 
 rabbit TNFα: IKSPCHRETPEEAEPMAWYEPIYLGGVFQLEKGDRLSTEVNQPEYLDLAE   145 
  human TNFβ:      QKMVYPGLQ EPWLHSMYHGAAFQLTQGDQLSTHTDGIPHLVLSP   161 
   Consensus: IKSPCQRETPEGAE-KPWYEPIYLGGVFQLEKGDRLSAE-N-P-YLDFAE 
 
                    H  
                 
  human TNFα: SGQVYFGIIAL                                          157 
 monkey TNFα: SGQVYFGIIAL                                          157 
 canine TNFα: SGQVYFGIIAL                                          157 
Porcine TNFα: SGQVYFGIIAL                                          156 
 murine TNFα: SGQVYFGVIAL                                          156 
 rabbit TNFα: SGQVYFGIIAL                                          156 
  human TNFβ: ST VFFGAFAL                                          171 
   Consensus: SGQVYFGIIAL 
Supplementary Figure 5. Sequence alignment of mammalian TNFα proteins and human TNFβ.
Secondary structures are indicated as arrows for β-strands. Residues colored red indicate that
the amino acid at this position contacts 2L in the 2L–human TNFα complex structure. Consensus
amino acid is shown when identity is >70%.
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